Emergency Medicine PHARMacotherapy research NETwork 🚨 Pushing the EM PharmD profession forward through high quality, collaborative research 📄
Joined February 2021
- Tweets73
- Following828
- Followers1.5K
- Likes78
EMPHARM-NET retweeted
📣 Check out the latest @EMPHARM_NET study of 362 adults with TBI or sICH at 11 US EDs who received sugammadex
📈 A positive response (⬆️GCS ≥1) was seen in 54% & associated with a new analgesia, sedation & non-significant⬆️neurosurgical procedures
👉sciencedirect.com/science/ar…
EMPHARM-NET retweeted
@bfaine1 & I penned an editorial called Pharmacists on the Front Lines: Advances in Emergency Medicine Pharmacy Practice on the history and advancement of EM pharmacy culminating in this EM themed issue🚨
academic.oup.com/ajhp/articl…
EMPHARM-NET retweeted
Excited to share the Emergency Medicine themed issue of @ASHPOfficial @AJHPOfficial that I guested edited w/ @bfaine1.
20 ( ‼️ ) papers & >50 EM pharmacists - this is a testament to how talented and diverse our EM pharmacy community is!
Read here 👉academic.oup.com/ajhp/issue/…
EMPHARM-NET retweeted
💡 Need one more reason to love your friendly EM pharmacist? Check out this @EMPHARM_NET SR/MA:
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for @American_Stroke @American_Heart to take notice?
Just published in #AJEM! 📄
#PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑
📉 Faster treatment
🤝 More interprofessionalism
🏥 Justification for expanding #EMPharmD services
doi.org/10.1016/j.ajem.2025.…
EMPHARM-NET retweeted
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight👉 jamanetwork.com/journals/jam…
EMPHARM-NET retweeted
So excited to announce that @SAEM_AEMP is officially an @SAEMonline Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you! @LRayRx @EmergPharm
EMPHARM-NET retweeted
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!!
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @SAEMonline
EMPHARM-NET retweeted
🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨
Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it:
sciencedirect.com/science/ar…
@MGottliebMD
🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD
EMPHARM-NET retweeted
🥊 Sugammadex should NOT be routinely used to reverse to reverse rocuronium for patients in the ED with @AM_EM_PharmD
kwnsfk27.r.eu-west-1.awstrac…
Shout out to @MeganARech and @MGottliebMD for their take on the pro side!
🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨
Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it:
sciencedirect.com/science/ar…
@MGottliebMD
🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD
EMPHARM-NET retweeted
📣 EM Colleagues & @SAEMonline Community 📣
Want to support EM PharmDs,
learn about EM pharmacotherapy, & help us move from IG ➡️ Academy? Join our interest group!
Instructions 👇
📢 Calling all EM Providers! Join us in our AEMP Interest Group at SAEM! See below about how to add our IG to your SAEM profile!
💊 Calling all EM Pharmacists! Help us grow our IG by sharing this information with your providers!
#AEMP @SAEMonline
EMPHARM-NET retweeted
Survey reveals U.S. emergency pharmacists adhere to ACLS guidelines, favor norepinephrine post-ROSC, and frequently use sodium bicarbonate and antibiotics. 💉🚑
#EmergencyMedicine #ACLS #Pharmacy
🚨New @EMPHARM_NET pub in @AJHPOfficial 🚨
💊Survey of EM pharmacist (23% response rate; n=174)
💊94% reported epinephrine in accordance with ACLS
💊Ca, Mg and NaHCO3 common adjunctive meds
💊81% use norepinephrine as post-ROSC pressor of choice, 17% epi
pubmed.ncbi.nlm.nih.gov/3899…
EMPHARM-NET retweeted
I want to talk to 17% of y'all 🤓
🚨New @EMPHARM_NET pub in @AJHPOfficial 🚨
💊Survey of EM pharmacist (23% response rate; n=174)
💊94% reported epinephrine in accordance with ACLS
💊Ca, Mg and NaHCO3 common adjunctive meds
💊81% use norepinephrine as post-ROSC pressor of choice, 17% epi
pubmed.ncbi.nlm.nih.gov/3899…
EMPHARM-NET retweeted
These are always a must read
🚨4th Annual @EMPHARM_NET pub🚨
EDucated: EM pharmacotherapy literature of 2023
@jlkoehl @CBthePHARMD @bfaine1 @MeganARech @DEZ_EM_Pharm @GilbertPharmD @gavin_howington @RxEmergency @giles_slocum @annezepeski @EMPoisonPharmD @ThePeoplesRuben
sciencedirect.com/science/ar…
EMPHARM-NET retweeted
Congrats @jlkoehl!! Thanks for taking all of 2023 and giving us the TLDR
Really fantastic Highyield round up of the articles/guidelines from 2023 that may change how you practice after 2023.
Available here: sciencedirect.com/science/ar…
Awesome group of people to work with as well!
EMPHARM-NET retweeted
Really fantastic Highyield round up of the articles/guidelines from 2023 that may change how you practice after 2023.
Available here: sciencedirect.com/science/ar…
Awesome group of people to work with as well!
🚨4th Annual @EMPHARM_NET pub🚨
EDucated: EM pharmacotherapy literature of 2023
@jlkoehl @CBthePHARMD @bfaine1 @MeganARech @DEZ_EM_Pharm @GilbertPharmD @gavin_howington @RxEmergency @giles_slocum @annezepeski @EMPoisonPharmD @ThePeoplesRuben
sciencedirect.com/science/ar…
EMPHARM-NET retweeted
👇New @EMPHARM_NET 2023 annual EM pharmacotherapy literature review just dropped 🔥
🚨4th Annual @EMPHARM_NET pub🚨
EDucated: EM pharmacotherapy literature of 2023
@jlkoehl @CBthePHARMD @bfaine1 @MeganARech @DEZ_EM_Pharm @GilbertPharmD @gavin_howington @RxEmergency @giles_slocum @annezepeski @EMPoisonPharmD @ThePeoplesRuben
sciencedirect.com/science/ar…
EMPHARM-NET retweeted
@EMPHARM_NET study shows that IV antibiotics are underutilized for pyelonephritis treatment in the ED and IV antibiotics decreased inactive therapy
doi.org/10.1093/jac/dkae070
@MeganARech @bfaine1 @ae_gross @CBthePHARMD @DEZ_EM_Pharm @RxEmergency @AM_EM_PharmD @AbbyMBaileyEM #JACNews
EMPHARM-NET retweeted
Free access link here 👉 academic.oup.com/jac/advance… – at Chicago, IL
🔥Hot off the press: @EMPHARM_NET study of 233 ED patients w/ pyelonephritis:
💉40% received IV antibiotics
💊 most common PO ABx: cephalexin, ciprofloxacin, cefdinir, & TMP-SMX
🦠Inactive therapy rate 10.3% & IV ABx ⬇️ odds of inactive therapy
pubmed.ncbi.nlm.nih.gov/3848…
EMPHARM-NET retweeted
🚑 #Pyelonephritis treatment in the ED under scrutiny: Study finds only 40.4% received IV antibiotics, leading to inactive therapy for some. But, hope shines with long-acting IV antibiotics linked to decreased risk of inactive treatment! 💊
#EmergencyMedicine #PatientCare
🔥Hot off the press: @EMPHARM_NET study of 233 ED patients w/ pyelonephritis:
💉40% received IV antibiotics
💊 most common PO ABx: cephalexin, ciprofloxacin, cefdinir, & TMP-SMX
🦠Inactive therapy rate 10.3% & IV ABx ⬇️ odds of inactive therapy
pubmed.ncbi.nlm.nih.gov/3848…
EMPHARM-NET retweeted
Such a high honor to serve as keynote 🔑 for the @SAEM_AEMP PharmERgency Conference with Dr Nick Mohr to lay out the our future plans for the Academy of EM Pharmacists and beyond! 💫
Excited to continue to build it together and meet in person in May 💃🪩
#AEMP24 @SAEMonline – at Chicago, IL
This Post is from an account that no longer exists. Learn more